森龍太郎 (MORI RYUTARO) - マイポータル

基本情報

所属: 岐阜大学医学部附属病院医療情報部副部長・講師

学位: 医学博士

J-GLOBAL ID: 201601018703859097
researchmap会員ID: 7000014390

研究分野

ライフサイエンス / 腫瘍診断、治療学 /

学歴

- 2013年3月

岐阜大学, 大学院医学系研究科博士課程, 医科学専攻

論文

Evaluation of histopathological heterogeneity of colorectal cancer liver metastasis sites after preoperative chemotherapy.

Nobuhisa Matsuhashi, Hiroyuki Tomita, Hidenori Tanaka, Yoshinori Iwata, Satoshi Matsui, Hisashi Imai, Masahiro Fukada, Chika Mizutani, Takao Takahashi, Itaru Yasufuku …

Molecular and clinical oncology 16(3) 61-61 2022年3月
The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis.

Takeharu Imai, Yoshihiro Tanaka, Yuta Sato, Junichi Mase, Tomonari Suetsugu, Masahiro Fukada, Itaru Yasufuku, Yoshinori Iwata, Ryutaro Mori, Hisashi Imai …

Indian journal of surgical oncology 1-9 2021年8月28日
Incidental cytokeratin-positive interstitial reticulum cell tumor of the lymph node accompanied by breast cancer: Status of YAP/TAZ expression in tumor cells

Chiemi Saigo, Yusuke Kito, Masayoshi Hasegawa, Shusuke Nomura, Takuya Mikamo, Yuki Hanamatsu, Ryutaro Mori, Manabu Futamura, Kazuhiro Yoshida, Tamotsu Takeuchi

Human Pathology: Case Reports 200526-200526 2021年6月
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.

Tomonari Suetsugu, Ryutaro Mori, Manabu Futamura, Masahiro Fukada, Hideharu Tanaka, Itaru Yasufuku, Yuta Sato, Yoshinori Iwata, Takeharu Imai, Hisashi Imai …

Oncology reports 45(4) 2021年4月
MIEAP, a p53-downstream gene, is associated with suppression of breast cancer cell proliferation and better survival.

Manabu Futamura, Yoshihisa Tokumaru, Kazuaki Takabe, Hirofumi Arakawa, Yoshimi Asano, Ryutaro Mori, Junichi Mase, Akira Nakakami, Kazuhiro Yoshida

American journal of cancer research 11(12) 6060-6073 2021年
Ascending colon cancer with synchronous right external iliac lymph node metastasis.

Yoshinori Iwata, Nobuhisa Matsuhashi, Takao Takahashi, Tomonari Suetsugu, Masahiro Fukada, Itaru Yasufuku, Takeharu Imai, Toshiyuki Tanahashi, Ryutaro Mori, Satoshi Matsui …

International cancer conference journal 9(3) 162-167 2020年7月査読有り
筋ジストロフィーに合併した巨大葉状腫瘍の1例

中神光, 二村学, 林祐一, 野口慶, 細野芳樹, 森龍太郎, 浅野好美, 吉田和弘

日本癌治療学会学術集会抄録集 57回 P7-1 2019年10月
HER2陽性胃癌に対する新規合成miR-143のKras network抑制による細胞増殖抑制効果

浅野好美, 徳丸剛久, 二村学, 中神光, 森龍太郎, 山口和也, 吉田和弘

日本癌治療学会学術集会抄録集 57回 P11-1 2019年10月
Combination chemotherapy with TAS-102 plus bevacizumab in salvage-line treatment of metastatic colorectal cancer: A single-center, retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage-line therapy of metastatic colorectal cancer.

Nobuhisa Matsuhashi, Takao Takahashi, Hironori Fujii, Tomonari Suetsugu, Masahiro Fukada, Yoshinori Iwata, Yoshihisa Tokumaru, Takeharu Imai, Ryutaro Mori, Toshiyuki Tanahashi …

Molecular and clinical oncology 11(4) 390-396 2019年10月査読有り
The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.

Ryutaro Mori, Kazuhiro Yoshida, Manabu Futamura, Tomonari Suetsugu, Kaoru Shizu, Toshiyuki Tanahashi, Yoshihiro Tanaka, Nobuhisha Matsuhashi, Kazuya Yamaguchi

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 22(3) 497-505 2019年5月査読有り
Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice

Wataru Shibata, Hiroto Kinoshita, Yohko Hikiba, Takeshi Sato, Yasuaki Ishii, Soichiro Sue, Makoto Sugimori, Nobumi Suzuki, Kosuke Sakitani, Hideaki Ijichi …

Scientific Reports 8(1) 2018年12月1日査読有り
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.

Siqin Gaowa, Manabu Futamura, Masayuki Tsuneki, Hiroki Kamino, Jesse Y Tajima, Ryutaro Mori, Hirofumi Arakawa, Kazuhiro Yoshida

Cancer science 109(12) 3910-3920 2018年12月査読有り
The mode of progressive disease affects the prognosis of patients with metastatic breast cancer.

Ryutaro Mori, Manabu Futamura, Kasumi Morimitsu, Yoshimi Asano, Yoshihisa Tokumaru, Mai Kitazawa, Kazuhiro Yoshida

World journal of surgical oncology 16(1) 169-169 2018年8月14日査読有り
[A Case of Stage IV Gastric Cancer Curative Resection by Conversion Therapy].

Hitoya Sano, Kazuya Yamaguchi, Toshiyuki Tanahashi, Takuji Sakuratani, Ryutaro Mori, Satoshi Matsui, Hisashi Imai, Yoshihiro Tanaka, Nobuhisa Matsuhashi, Takao Takahashi …

Gan to kagaku ryoho. Cancer & chemotherapy 45(3) 465-467 2018年3月査読有り
Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer.

Minako Nawa-Nishigaki, Ryo Kobayashi, Akio Suzuki, Chiemi Hirose, Rie Matsuoka, Ryutaro Mori, Manabu Futamura, Tadashi Sugiyama, Kazuhiro Yoshida, Yoshinori Itoh

Anticancer research 38(2) 877-884 2018年2月査読有り
Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer.

Jesse Yu Tajima, Manabu Futamura, Siqin Gaowa, Ryutaro Mori, Toshiyuki Tanahashi, Yoshihiro Tanaka, Nobuhisa Matsuhashi, Takao Takahashi, Kazuya Yamaguchi, Tatsuhiko Miyazaki …

Journal of Cancer 9(2) 358-366 2018年査読有り
Immunohistochemical comparison of malignancy between radial invasion and mucosal extension in hilar cholangiocarcinoma

Kenichi Yoshida, Ryusei Matsuyama, Ryutaro Mori, Takafumi Kumamoto, Kenichi Matsuo, Kazuhisa Takeda, Mitsutaka Sugita, Yoshiro Fujii, Kuniya Tanaka, Hiroshi Shimada …

Anticancer Research 37(10) 5805-5812 2017年10月1日査読有り
5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine.

Ryutaro Mori, Manabu Futamura, Toshiyuki Tanahashi, Yoshihiro Tanaka, Nobuhisha Matsuhashi, Kazuya Yamaguchi, Kazuhiro Yoshida

Oncology letters 14(3) 3162-3168 2017年9月査読有り
Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.

Manabu Futamura, Yasuko Nagao, Kazuhiro Ishihara, Makoto Takeuchi, Takumi Nakada, Yoshihiro Kawaguchi, Masayoshi Asano, Iwao Kumazawa, Takashi Shiroko, Kasumi Morimitsu …

Breast cancer (Tokyo, Japan) 24(4) 615-623 2017年7月査読有り
The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.

Ryutaro Mori, Manabu Futamura, Kasumi Morimitsu, Chiemi Saigo, Tatsuhiko Miyazaki, Kazuhiro Yoshida

World journal of surgical oncology 15(1) 117-117 2017年6月29日査読有り

もっとみる

MISC

乳癌アントラサイクリン/シクロホスファミド併用療法に対する制吐対策としてのオランザピンの有効性の評価

小林亮, 名和美奈子, 廣瀬智恵美, 松岡梨恵, 鈴木昭夫, 森龍太郎, 二村学, 杉山正, 吉田和弘, 伊藤善規

日本薬学会年会要旨集(CD-ROM) 138th 2018年
Pancreaticoduodenectomy with arterial resection and reconstruction

Takashi Murakami, Ryusei Matsuyama, Ryutaro Mori, Takafumi Kumamoto, Yu Sawada, Yasuhiro Yabushita, Nobuhiro Tsuchiya, Yuki Homma, Itaru Endo

Japanese Journal of Cancer and Chemotherapy 44(10) 849-853 2017年10月1日
Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status.

Junko Kato, Manabu Futamura, Masako Kanematsu, Siqin Gaowa, Ryutaro Mori, Toshiyuki Tanahashi, Nobuhisa Matsuhashi, Kazuhiro Yoshida

International journal of cancer 138(6) 1516-27 2016年3月15日査読有り
Clinical significance and possible role of GPNMB in patients with breast cancer

Manabu Futamura, Masako Kanematsu, Atsuko Yamada, Kasumi Morimitsu, Akemi Morikawa, Ryutaro Mori, Kazuhiro Yoshida

CANCER RESEARCH 75 2015年8月
The PerSeUS-BC01 study: A phase II study of nab-PTX followed by EC as neoadjuvant chemotherapy in breast cancer patients.

Manabu Futamura, Yasuko Nagao, Kazuhiro Ishihara, Makoto Takeuchi, Takumi Nakada, Yoshihiro Kawaguchi, Masayoshi Asano, Iwao Kumazawa, Takashi Shiroko, Ryutaro Mori …

JOURNAL OF CLINICAL ONCOLOGY 33(15) 2015年5月
Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.

Toshiyuki Tanahashi, Shinji Osada, Atsuko Yamada, Junko Kato, Kazunori Yawata, Ryutaro Mori, Hisashi Imai, Yoshiyuki Sasaki, Shiro Saito, Yoshihiro Tanaka …

International journal of oncology 42(2) 556-64 2013年2月査読有り
Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer.

Shuji Komori, Shinji Osada, Ryutaro Mori, Satoshi Matsui, Yuichi Sanada, Hiroyuki Tomita, Yasuharu Tokuyama, Takao Takahashi, Kazuya Yamaguchi, Kazuhiro Yoshida

Pancreas 39(8) 1284-92 2010年11月査読有り
Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.

Satoshi Matsui, Shinji Osada, Hiroyuki Tomita, Shuji Komori, Ryutaro Mori, Yuichi Sanada, Takao Takahashi, Kazuya Yamaguchi, Kazuhiro Yoshida

International journal of oncology 37(2) 289-97 2010年8月査読有り

書籍等出版物

DCISの診断と治療－最新動向－②治療編、 DCISの薬物療法(ホルモン＆分子標的)

森龍太郎, 佐治重衡

2012年12月
術後化学療法、乳癌、具体的なレジメンと, 施行の実際－ホルモン療法

森龍太郎, 佐治重衡

2012年2月

共同研究・競争的資金等の研究課題

乳癌における5FU作用機序の違いによる耐性機序の違いとその克服

日本学術振興会科学研究費助成事業基盤研究(C) 2019年4月 - 2022年3月

森龍太郎
数理情報解析システムを用いたドラッグ・リポジショニングによる5-FU耐性機序解明

日本学術振興会科学研究費助成事業基盤研究(C) 2016年4月 - 2019年3月

森龍太郎

その他

日本外科学会外科専門医

森龍太郎

基本情報

研究分野

学歴

論文

MISC

書籍等出版物

共同研究・競争的資金等の研究課題

その他

メニュー

共著者の一覧